| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kim Hanjoon Alex | Chief Financial Officer | C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO | /s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact | 2025-08-05 | 0001919209 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Award | $0 | +1.5M | +159.48% | $0.00 | 2.44M | Aug 1, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units ("RSUs") that vest as to 40% of the RSUs on July 20, 2026, with the remaining 60% of the RSUs vesting on July 20, 2027, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| F2 | Includes an aggregate of 12,861 shares of common stock previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan. |